UDP-glucuronosyltransferases (UGTs): from purification of Ah-receptor–inducible UGT1A6 to coordinate regulation of subsets of CYPs, UGTs, and ABC transporters by nuclear receptors

References

• Abid, A., Bouchon, I., Siest, G., Sabolovic, N. (1995). Glucuronidation in the Caco-2 intestinal cell line: induction of UDP-glucuronosyltransferase 1*6. Biochem Pharmacol 50:557–561.
   PubMed Web of Science ®Google Scholar
• Benoit-Biancamano, M. O., Connelly, J., Villeneuve, L., Caron, P., Guillemette, C. (2009). Deferiprone glucuronidation by human tissues and recombinant UDP glucuronosyltransferase 1A6: an in vitro investigation of genetic and splice variants. Drug Metab Disp 37:322–329.
   PubMed Web of Science ®Google Scholar
• Bock, K. W. (1974). Oxidation of barbiturates and the glucuronidation of 1-naphthol in perfused rat liver and in microsomes. Naunyn-Schmiedeberg’s Arch Pharmacol 283:319–330.
   Google Scholar
• Bock, K. W. (2003). Vertebrate UDP-glucuronosyltransferases: functional and evolutionary aspects. Biochem Pharmacol 66:691–696.
   PubMed Web of Science ®Google Scholar
• Bock, K. W., Bock-Hennig, B. S. (1987). Differential induction of human liver UDP-glucuronosyltransferase activities by phenobarbital-type inducers. Biochem Pharmacol 36:4137–4143.
   PubMed Web of Science ®Google Scholar
• Bock, K. W., Köhle, C. (2006). Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem Pharmacol 72:393–404.
   PubMed Web of Science ®Google Scholar
• Bock, K. W., Köhle, C. (2009). Topological aspects of oligomeric UDP-glucuronosyltransferases in endoplasmic reticulum membranes: advances and open questions. Biochem Pharmacol 77:1458–1465.
   PubMed Web of Science ®Google Scholar
• Bock, K. W., White, I. (1974). UDP-glucuronyltransferase in perfused rat liver and in microsomes: influence of phenobarbital and 3-methylcholanthrene. Eur J Biochem 46:451–459.
   PubMedGoogle Scholar
• Bock, K. W., Eckle, T., Ouzzine, M., Fournel-Gigleux, S. (2000). Coordinate induction by antioxidants of UDP-glucuronosyltransferase UGT1A6 and the apical export pump, MRP2 (multidrug resistance protein 2), in Caco-2 cells. Biochem Pharmacol 59:467–470.
   PubMed Web of Science ®Google Scholar
• Bock, K. W., Forster, A., Gschaidmeier H., Brück, M, Münzel, P., Scharek, W., Fournel-Gigleux, S., et al. (1993). Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases. Biochem Pharmacol 45:1809–1814.
   PubMed Web of Science ®Google Scholar
• Bock, K. W., Fröhling, W., Remmer, H., Rexer, B. (1973). Effects of phenobarbital and 3-methylcholanthrene on substrate specificity of rat liver microsomal UDP-glucuronyltransferase. Biochim Biophys Acta 327:46–56.
   PubMed Web of Science ®Google Scholar
• Bock, K. W., Gschaidmeier, H., Seidel, A., Baird, B., Burchell, B. (1992). Mono- and diglucuronide formation from chrysene and benzo(a)pyrene phenols by 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase (UGT1A1). Mol Pharmacol 42:613–618.
   PubMed Web of Science ®Google Scholar
• Bock, K. W., Josting, D., Lilienblum, W., Pfeil, H. (1979). Purification of rat liver microsomal UDP-glucuronyltransferase. Separation of two enzyme forms inducible by 3-methylcholanthrene or phenobarbital. Eur J Biochem 98:19–26.
   PubMedGoogle Scholar
• Bock, K. W., Lilienblum, W., Pfeil, H. (1982). Functional heterogeneity of UDP-glucuronosyltransferase activities in C57BL/6 and DBA/2 mice. Biochem Pharmacol 31:1273–1277.
   PubMed Web of Science ®Google Scholar
• Bock, K. W., Lilienblum, W., von Bahr, C. (1984). Studies of UDP-glucuroyltransferase activities in human liver microsomes. Drug Metab Disp 12:93–97.
   PubMed Web of Science ®Google Scholar
• Bock, K. W., Lipp, H. P., Bock-Hennig, B. S. (1990b). Induction of drug-metabolizing enzymes by xenobiotics. Xenobiotica 20:1101–1111.
   PubMed Web of Science ®Google Scholar
• Bock, K. W., Münzel, P. A., Röhrdanz, E., Schrenk, D., Eriksson, L. C. (1990a). Persistently increased expression of a 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase in rat hepatocyte nodules and hepatocellular carcinomas. Cancer Res 50:3569–3573.
   PubMed Web of Science ®Google Scholar
• Bock, K. W., Schirmer, G., Green, M. D., Tephly, T. R. (1988). Properties of a 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase from rat liver. Biochem Pharmacol 37:1439–1443.
   PubMed Web of Science ®Google Scholar
• Bock, K. W., Schrenk, D., Forster, A., Griese, E. U., Mörike, K., Brockmeier, D., et al. (1994). The influence of environmental and genetic factors on CYP2D6, CYP1A2, and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes. Pharmacogenetics 4:209–218.
   PubMedGoogle Scholar
• Bock, K. W., Wiltfang, J., Blume, R., Ullrich, D., Bircher J. (1987). Paracetamol as a test drug to determine glucuronide formation in man: effects of inducers and of smoking. Eur J Clin Pharmacol 31:677–683.
   PubMed Web of Science ®Google Scholar
• Bock-Hennig, B. S., Köhle, C., Nill, K., Bock, K. W. (2002). Influence of t-butylhydroquinone and β-naphthoflavone on formation and transport of 4-methylumbelliferone glucuronide in Caco-2/TC-7 cell monolayers. Biochem Pharmacol 63:123–128.
   PubMed Web of Science ®Google Scholar
• Braeuning, A., Sanna, R., Huelsken, J., Schwarz, M. (2009). Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1. Drug Metab Disp 37:1138–1145.
   PubMed Web of Science ®Google Scholar
• Brands, A., Münzel, P. A., Bock, K. W. (2000). In situ hybridization studies of UDP-glucuronosyltransferase UGT1A6 expression in rat testis and brain. Biochem Pharmacol 59:1441–1444.
   PubMed Web of Science ®Google Scholar
• Chen, S., Beaton, D., Nguyen, N., Senekeo-Effenberger, K., Brace-Sinnokrak, E., Argikar, U., et al. (2005). Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus. J Biol Chem 280:37547–37557.
   PubMed Web of Science ®Google Scholar
• Chiaro, C. R., Patel, R. D., Marcus, C. B., Perdew, G. H. (2007). Evidence for an aryl hydrocarbon receptor-mediated cytochrome P450 autoregulatory pathway. Mol Pharmacol 72:1369–1379.
   PubMed Web of Science ®Google Scholar
• Court, M. H., Duan, S. X., von Moltke, L.L., Greenblatt, D. J., Patten, C. J., Miners, J. O., et al. (2001). Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther 299:998–1006.
   PubMed Web of Science ®Google Scholar
• Crespy, V., Morand, C., Manach, C., Besson, C., Demigne, C., Remesy, C. (1999). Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen. Am J Physiol 277(Gastrointest Liver Physiol 40):G120–G126.
   PubMedGoogle Scholar
• Dutton, G. J. (1975). Control of UDP-glucuronyltransferase activity. Biochem Pharmacol 24:1835–1841.
   PubMed Web of Science ®Google Scholar
• Emi, Y., Ikushiro, S., Iyanagi, T. (1996). Xenobiotic responsive element-mediated transcriptional activation in the UDP-glucuronosyltransferase family 1 gene complex. J Biol Chem 271:3952–3958.
   PubMed Web of Science ®Google Scholar
• Estabrook, R. W. (1971). Cytochrome P-450: its function in the oxidative metabolism of drugs. Handbook Exp Pharmacol 28:264–284.
   Google Scholar
• Falany, C., Tephly, T. R. (1983). Separation, purification, and characterization of three isoenzymes of UDP-glucuronyltransferase from rat liver microsomes. Arch Biochem Biophys 227:248–258.
   PubMed Web of Science ®Google Scholar
• Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S. T., Kimura, S., et al. (1995). Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268:722–726.
   PubMed Web of Science ®Google Scholar
• Gschaidmeier, H., Bock, K. W. (1994). Radiation inactivation analysis of microsomal UDP-glucuronosyltransferases catalyzing mono- and diglucuronide formation of 3,6-dihydroxybenzo(a)pyrene and 3,6-dihydroxychrysene. Biochem Pharmacol 48:1545–1549.
   PubMed Web of Science ®Google Scholar
• Gschaidmeier, H., Seidel, A., Burchell, B., Bock, K. W. (1995). Formation of mono- and diglucuronides and other glycosides of benzo[a]pyrene-3,6-quinol by V79 cell-expressed human phenol UDP-glucuronosyltransferases of the UGT1 gene complex. Biochem Pharmacol 49:1601–1606.
   PubMed Web of Science ®Google Scholar
• Gu, Y. Z., Hogenesch, J. B., Bradfield, C. A. (2000). The PAS superfamily: sensors of environmental and developmental signals. Ann Rev Pharmacol Toxicol 40:519–561.
   PubMed Web of Science ®Google Scholar
• Inscoe, J. K., Axelrod, J. (1960). Some factors affecting glucuronide formation in vitro. J Pharmacol Exp Ther 129:128–131.
   PubMed Web of Science ®Google Scholar
• Iyanagi, T., Haniu, M., Sogawa, K., Fujii-Kuriyama, Y., Watanabe, S., Shively, J. E., et al. (1986). Cloning and characterization of cDNA encoding 3-methylcholanthrene inducible rat mRNA for UDP-glucuronosyltransferase. J Biol Chem 261:15607–15614.
   PubMed Web of Science ®Google Scholar
• Jaffe, S. J., Levy, D., Matsusawe, T., Baliah, T. (1966). Enhancement of glucuronide conjugating capacity in a hyperbilirubinemic infant due to apparent enzyme induction by phenobarbital. NEJM 275:461.
   Google Scholar
• Kerkvliet, N. I. (2009). AHR-mediated immunomudulation: the role of altered gene transcription. Biochem Pharmacol 77:746–760.
   PubMed Web of Science ®Google Scholar
• King, C. D., Rios, G. R., Assouline, J. A., Tephly, T. R. (1999). Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate. Arch Biochem Biophys 365:156–162.
   PubMed Web of Science ®Google Scholar
• Köhle, C., Bock, K. W. (2007). Coordinate regulation of phase I and II xenobiotic metabolism by the Ah receptor and Nrf2. Biochem Pharmacol 72:795–805.
   Google Scholar
• Köhle, C., Bock, K. W. (2009). Coordinate regulation of human drug-metabolizing enzymes and conjugate transporters by the Ah receptor, pregnane X receptor, and constitutive androstane receptor. Biochem Pharmacol 73:1853–1862.
   Google Scholar
• Köhle, C., Badary, O. A., Nill, K., Bock-Hennig, B. S., Bock, K. W. (2005). Serotonin glucuronidation by Ah receptor- and oxidative stress-inducible human UDP-glucuronosyltransferase (UGT) 1A6 in Caco-2 cells. Biochem Pharmacol 69:1397–1402.
   PubMed Web of Science ®Google Scholar
• Köhle, C., Schwarz, M., Bock, K. W. (2008). Promotion of hepatocarcinogenesis in humans and animal models. Arch Toxicol 82:623–631.
   PubMed Web of Science ®Google Scholar
• Krishnaswamy, S., Duan, S. X., von Moltke, L.L., Greenblatt, D. J., Court, M. H. (2003). Validation of serotonin (5-hydroxytryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6. Drug Metab Disp 31:133–139.
   PubMed Web of Science ®Google Scholar
• Krishnaswamy, S., Hao, Q., Al-Rohaimi, A., Hesse, L. M., von Moltke, L. L., Greenblatt, D. J., et al. (2005a). UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5’-regulatory and exon 1 regions, association with human liver UGT1A6 gene expression, and glucuronidation. J Pharmacol Exp Ther 313:1331–1339.
   PubMed Web of Science ®Google Scholar
• Krishnaswamy, S., Hao, Q., Al-Rohaimi, A., Hesse, L. M., von Moltke, L.L., Greenblatt, D. J., et al. (2005b) UDP-glucuronosyltransferase (UGT) 1A6 pharmacogenetics: II. Functional impact of the three most common nonsynonymous UDP1A6 polymorphisms (S7A, T181A, and R184S). J Pharmacol Exp Ther 313:1340–1346.
   PubMed Web of Science ®Google Scholar
• Lilienblum, W., Bock-Hennig, B. S., Bock, K. W. (1985). Protection against toxic redox cycles between benzo(a)pyrene-3,6-quinone and its quinol by 3-methylcholanthrene-inducible formation of the quinol mono- and diglucuronide. Mol Pharmacol 27:451–458.
   PubMed Web of Science ®Google Scholar
• Little, J. M., Kurkela, M., Sonka, J., Jäntti, S., Ketola, R., Bratton, S., et al. (2004). Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases. J Lipid Res 45:1694–1703.
   PubMed Web of Science ®Google Scholar
• Mackenzie, P. I. (1986). Rat liver UDP-glucuronosyltransferase: sequence and expression of a cDNA encoding a phenobarbital-inducible form. J Biol Chem 261:6119–6125.
   PubMed Web of Science ®Google Scholar
• Mackenzie, P. I., Bock, K. W., Burchell, B., Guillemette, C., Ikushiro, S., Iyanagi, T., et al. (2005). Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genom 15:677–685.
   PubMed Web of Science ®Google Scholar
• Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., et al. (1997). The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255–269.
   PubMedGoogle Scholar
• Maglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D., Moore, J. T., Kliewer, S. A. (2002). Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol 62:638–646.
   PubMed Web of Science ®Google Scholar
• Maines, M. D. (2005). New insights into biliverdin reductase functions: linking heme metabolism to cell signaling. Physiology 20:382–389.
   PubMed Web of Science ®Google Scholar
• Maron, D. M., Ames, B. N. (1983). Revised methods for the Salmonella mutagenicity test. Mutat Res 113:173–215.
   PubMed Web of Science ®Google Scholar
• Münzel, P. A., Brück, M., Bock, K. W. (1994). Tissue-specific constitutive and inducible expression of rat phenol UDP-glucuronyltransferase. Biochem Pharmacol 47:1445–1448.
   PubMed Web of Science ®Google Scholar
• Münzel, P. A., Lehmköster, T., Brück, M., Ritter, J. K., Bock, K. W. (1998). Aryl hydrocarbon receptor-inducible or constitutive expression of human UDP glucuronosyltransferase UGT1A6. Arch Biochem Biophys 350:72–78.
   PubMed Web of Science ®Google Scholar
• Münzel, P. A., Schmohl, S., Buckler, F., Jaehrling, J., Raschko, F. T., Köhle, C., et al. (2003). Contribution of the Ah receptor to the phenolic antioxidant-mediated expression of human and rat UDP-glucuronosyltransferase UGT1A6 in Caco-2 and rat hepatoma 5L cells. Biochem Pharmacol 66:841–847.
   PubMed Web of Science ®Google Scholar
• Nebert, D. W., Dalton, T. P., Okey, A. B., Gonzalez, F. J. (2004). Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279:23847–23850.
   PubMed Web of Science ®Google Scholar
• Nguyen, L-P., Bradfield, C. A. (2008). The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 21:102–116.
   PubMed Web of Science ®Google Scholar
• Orzechowski, A., Schrenk, D., Bock-Hennig, B. S., Bock, K. W. (1994). Glucuronidation of carcinogenic arylamines and their N-hydroxy derivatives by rat and human phenol UDP-glucuronosyltransferases of the UGT1 gene complex. Carcinogenesis 15:1549–1553.
   PubMed Web of Science ®Google Scholar
• Owens, I. S. (1977). Genetic regulation of UDP-glucuronosyltransferase induction by polycyclic aromatic compounds in mice. J Biol Chem 252:2827–2833.
   PubMed Web of Science ®Google Scholar
• Patel, R. D., Hollingshead, B. D., Omiecinski, C. J., Perdew, G. H. (2007). Aryl-hydrocarbon receptor activation regulates constitutive androstane receptor levels in murine and human liver. Mol Pharmacol 46:209–218.
   Google Scholar
• Phelan, D., Winter, G. M., Rogers, W. J., Lam, J. C., Denison, M. S. (1998). Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch Biochem Biophys 357:155–163.
   PubMed Web of Science ®Google Scholar
• Ritter, J. K., Kessler, F. K., Thompson, M. T., Grove, A. D., Auyeung, D. J., Fisher, R. A. (1999). Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: evidence for both genetic and environmental influences. Hepatology 30:476–484.
   PubMed Web of Science ®Google Scholar
• Sedlak, T. W., Saleh, M., Higginson, D. S., Paul, B. D., Juluri, K. R., Snyder, S. H. (2009). Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci U S A 106:5171–5176.
   PubMed Web of Science ®Google Scholar
• Sinal, C. P., Bend, J. P. (1997). Aryl hydrocarbon receptor-dependent induction of CYP1a1 by bilirubin in mouse hepatoma Hepa 1c1c7 cells. Mol Pharmacol 52:590–599.
   PubMed Web of Science ®Google Scholar
• Soars, M. G., Petullo, D. M., Eckstein, J. A., Kasper, S. C., Wrighton, S. A. (2004). An assessment of UGP-glucuronosyltransferase induction using primary human hepatocytes. Drug Metab Disp 32:140–148.
   PubMed Web of Science ®Google Scholar
• Stramentinoli, G., Gazzaniga, A., Della Bella, D., Remmer, H. (1974). Increase of chloramphenicol glucuronidation in rats treated with phenobarbital. Biochem Pharmacol 23:1181–1186.
   PubMed Web of Science ®Google Scholar
• Sugatani, J., Sueoshi, T., Negishi, M., Miva, M. (2005). Regulation of the human UGT1A1 gene by nuclear receptors constitutive active/androstane receptor, pregnane X receptor, and glucocorticoid receptor. Meth Enzymol 400:92–104.
   PubMed Web of Science ®Google Scholar
• Toriyabe, T., Nagata, K., Takada T., Aratsu, Y., Matsubara, T., Yoshinari, K., et al. (2009). Unveiling a new essential cis-element for transactivation of the CYP3A4 gene by xenobiotics. Mol Pharmacol 75:677–684.
   PubMed Web of Science ®Google Scholar
• Walle, U. K., Galijatovic, A., Walle, T. (1999). Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line, Caco-2. Biochem Pharmacol 58:431–438.
   PubMed Web of Science ®Google Scholar
• Yueh, M. F., Huang, Y. H., Hiller, A., Chen, S., Nguyen, N., Tukey, R. H. (2003). Involvement of the xenobiotic element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1. J Biol Chem 276:15001–15006.
   Google Scholar